U.K. opens center to developing biologics manufacturing processes

The U.K.'s Centre for Process Innovation (CPI) has completed and opened its £38 million ($57.5 million) facility devoted to the research and development of new process for manufacturing biologics. The facility, announced in 2012, is part of the country's effort to improve its standing in the industry. The new National Biologics Manufacturing Centre (NBMC) is in Darlington, Co. Durham. Report

Suggested Articles

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.

Boehringer Ingelheim is investing $50 million in an animal health plant in Puerto Rico, adding 105 jobs.

Teva will begin producing chemo drug vincristine in the U.S. but has resisted the idea that its withdrawal from the market led to a shortage.